{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:22:47Z","timestamp":1783135367418,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573617"],"award-info":[{"award-number":["82573617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L248050"],"award-info":[{"award-number":["L248050"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242119"],"award-info":[{"award-number":["7242119"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218532","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:01:13Z","timestamp":1776873673000},"page":"218532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity"],"prefix":"10.1016","volume":"651","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianle","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-8852","authenticated-orcid":false,"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218532_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218532_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218532_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamaoncol.2024.5356","article-title":"Deep learning model for predicting immunotherapy response in advanced non-small cell lung cancer","volume":"11","author":"Rakaee","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218532_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218532_bib5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s43018-025-00992-5","article-title":"The current and emerging immunotherapy paradigm in small-cell lung cancer","volume":"6","author":"Qin","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218532_bib6","article-title":"Gab docking proteins in cardiovascular disease, cancer, and inflammation","volume":"2013","author":"Nakaoka","year":"2013","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.canlet.2026.218532_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1349-7006.2003.tb01396.x","article-title":"The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors","volume":"94","author":"Nishida","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218532_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115024","article-title":"Pleckstrin homology [PH] domain, structure, mechanism, and contribution to human disease","volume":"165","author":"Powis","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218532_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-811X-7-22","article-title":"Function, regulation and pathological roles of the Gab\/DOS docking proteins","volume":"7","author":"Wohrle","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218532_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164179","article-title":"The role of GAB1 in cancer","volume":"15","author":"Perez-Baena","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218532_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2353\/ajpath.2009.080543","article-title":"Gab2-mediated signaling promotes melanoma metastasis","volume":"174","author":"Horst","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218532_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fimmu.2019.00486","article-title":"Gab2 and Gab3 redundantly suppress colitis by modulating macrophage and CD8(+) T-Cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218532_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav3866","article-title":"Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy","volume":"4","author":"Sliz","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218532_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12079-020-00582-3","article-title":"GAB2 and GAB3 are expressed in a tumor stage-, grade- and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer","volume":"15","author":"Berkel","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218532_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2017.01.095","article-title":"Gab3 is required for human colorectal cancer cell proliferation","volume":"484","author":"Xiang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218532_bib16","article-title":"Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation","volume":"12","author":"Jia","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218532_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41392-023-01612-3","article-title":"CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218532_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218532_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218532_bib20","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/pr501254j","article-title":"The CPTAC data portal: a resource for cancer proteomics research","volume":"14","author":"Edwards","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2026.218532_bib21","article-title":"Identification, functional insights and therapeutic targeting of EMT tumour states","author":"Dong","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218532_bib22","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.celrep.2018.11.103","article-title":"Dual mechanisms of LYN kinase dysregulation drive aggressive behavior in breast cancer cells","volume":"25","author":"Tornillo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218532_bib23","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050211","article-title":"Conditional in vivo deletion of LYN kinase has little effect on a BRCA1 loss-of-function-associated mammary tumour model","volume":"17","author":"Tornillo","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.canlet.2026.218532_bib24","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1038\/s41598-019-42228-4","article-title":"Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn\/PI3K\/Akt and MAPK\/ERK pathways","volume":"9","author":"Ruiz-Medina","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218532_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218532_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218532_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41420-022-01073-7","article-title":"Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB\/AP-1 pathway and TLR4 expression","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218532_bib28","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.7150\/ijbs.70708","article-title":"Minocycline binds and inhibits LYN activity to prevent STAT3-meditated metastasis of colorectal cancer","volume":"18","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218532_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40779-023-00460-0","article-title":"Aspartoacylase suppresses prostate cancer progression by blocking LYN activation","volume":"10","author":"Weng","year":"2023","journal-title":"Milit. Med. Res."},{"key":"10.1016\/j.canlet.2026.218532_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41571-018-0105-0","article-title":"Therapeutic strategies to target RAS-mutant cancers","volume":"15","author":"Ryan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218532_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218532_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1164\/rccm.202109-2133OC","article-title":"Characterization of immunopathology and small airway remodeling in constrictive bronchiolitis","volume":"206","author":"Gutor","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2026.218532_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001823","article-title":"Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma","volume":"9","author":"Dai","year":"2021","journal-title":"J. Immunother. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:12:55Z","timestamp":1783134775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"alternative-id":["S0304383526002958"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218532","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218532"}}